Ingredion (INGR) Cash & Equivalents (2009 - 2026)

Ingredion's Cash & Equivalents history runs 18 years deep, the most recent figure standing at $914.0 million for Q1 2026.

• Quarterly Cash & Equivalents rose 9.2% year-over-year to $914.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $914.0 million (up 9.2% YoY) and the FY2025 annual result came in at $1.0 billion, up 3.31% from the prior year.
• Cash & Equivalents was $914.0 million for Q1 2026 at Ingredion, down from $1.0 billion in the prior quarter.
• Across five years, Cash & Equivalents topped out at $1.0 billion in Q4 2025 and bottomed at $236.0 million in Q4 2022.
• A 5-year average of $596.2 million and a median of $471.5 million in 2024 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2022 — Cash & Equivalents tumbled 43.75% — and 2024, when it soared 161.79%.
• Ingredion's Cash & Equivalents stood at $236.0 million in 2022, then surged by 69.92% to $401.0 million in 2023, then jumped by 148.63% to $997.0 million in 2024, then rose by 3.31% to $1.0 billion in 2025, then declined by 11.26% to $914.0 million in 2026.
• Business Quant data shows INGR's Cash & Equivalents at $914.0 million in Q1 2026, $1.0 billion in Q4 2025, and $915.0 million in Q3 2025.